The development of custom nanoparticles for RNAi delivery is transforming gene therapy approaches. These nanoparticles enhance the stability and efficiency of RNA interference molecules, overcoming biological barriers for targeted therapies. By utilizing modular designs, researchers can tailor nanoparticles with specific ligands for targeted delivery, ensuring greater therapeutic effectiveness in various diseases, including cancers.